Log in
Enquire now

List of funding rounds for Alnylam Pharmaceuticals

List of funding rounds for Alnylam Pharmaceuticals
List of funding rounds for ClusterTruck, Inc.
List of funding rounds for Redis
List of funding rounds for Harness
List of SBIR/STTR awards granted to synvitrobio
List of Navvis patents
Funding Rounds where
Funded Company
Name
is
Alnylam PharmaceuticalsAlnylam Pharmaceuticals
Name
Description
Funding Type
Funded Company
Funding Round Amount (USD)
Investment
Funding Round Date
‌
Alnylam Pharmaceuticals Venture round, July 2003

Alnylam Pharmaceuticals raised a Venture round for 24,600,000 USD in July, 2003.

‌
Venture round
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
24,600,000
Investor
Abingworth
Abingworth
Investor
Cardinal Partners
Cardinal Partners
Investor
Merck Group
Merck Group
Investor
ARCH Venture Partners
ARCH Venture Partners
July 7, 2003
‌
Alnylam Pharmaceuticals Private equity, April 2019

Alnylam Pharmaceuticals raised a Private equity for 800,000 USD in April, 2019.

Private equity
Private equity
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
800,000
Investor
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
April 8, 2019
‌
Alnylam Pharmaceuticals funding round, March 2011

Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
10,000,000
Investor
March 28, 2011
‌
Alnylam Pharmaceuticals Private equity, January 2014

Alnylam Pharmaceuticals raised a Private equity for 700,000 USD in January, 2014.

Private equity
Private equity
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
700,000
Investor
Genzyme
Genzyme
January 13, 2014
‌
Alnylam Pharmaceuticals Private equity, August 2020

Alnylam Pharmaceuticals raised a Private equity in April, 2020.

Private equity
Private equity
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Investor
Blackstone Life Sciences
Blackstone Life Sciences
April 17, 2020
‌
Alnylam Pharmaceuticals Private equity, April 2020

Alnylam Pharmaceuticals raised a Private equity for 100,000,000 USD in April, 2020.

Private equity
Private equity
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
100,000,000
Investor
Blackstone Life Sciences
Blackstone Life Sciences
April 13, 2020
‌
Alnylam Pharmaceuticals Private equity, April 2020

Alnylam Pharmaceuticals raised a Private equity for 750,000,000 USD in April, 2020.

Private equity
Private equity
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
750,000,000
Investor
GSO Capital Partners
GSO Capital Partners
April 13, 2020
7 results
0 selected
7 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us